Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis

Objective When patients take neuroleptics, the distinction between Parkinson's disease (PD) and drug-induced parkinsonism (DIP) based solely on clinical features can become difficult. At present, 123I-FP-CIT SPECT (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy are w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2020/02/15, Vol.59(4), pp.485-490
Hauptverfasser:	Tachibana, Kei, Matsuura, Keita, Shindo, Akihiro, Matsuyama, Hirofumi, Ii, Yuichiro, Taniguchi, Akira, Tomimoto, Hidekazu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antipsychotic Agents - adverse effects Antipsychotics asymmetric autonomic dysfunction Basal ganglia Central nervous system diseases Diagnosis, Differential Differential diagnosis Dopamine receptors dopamine transporter single-photon emission computed tomography drug induced parkinsonism Female Functional Neuroimaging - methods Humans Internal medicine Levodopa Magnetic resonance imaging Male Mediastinum Middle Aged Movement disorders Neurodegenerative diseases Neuroimaging Original Parkinson disease Parkinson Disease - diagnostic imaging Parkinson Disease, Secondary - chemically induced Parkinson's disease Parkinsonian Disorders - chemically induced Parkinsonian Disorders - diagnostic imaging Patients Scintigraphy Single photon emission computed tomography Symptom Assessment tremor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!